Resultados de la búsqueda 181-190 of 16771 for mesenteric panniculitis

  1. Hematología - Ensayos clínicos - Mayo Clinic

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the growth ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  5. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to follow Mayo Clinic patients with severe brachial plexus injuries who underwent upper limb amputation. Digital ...

  7. Síntomas y causas - Mayo Clinic

    Otras causas de la linfadenitis mesentérica son, por ejemplo, las infecciones bacterianas, la enfermedad inflamatoria intestinal y el linfoma. Factores de ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

  9. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

  10. Mayo Clinic Digestive Diseases Physician Update e-Edition, June 2015

    Bile acid malabsorption (BAM)) occurs in about 1 in 3 patients with IBS-D and up to 50 percent of those with functional diarrhea, yet it remains underdiagnosed.